• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Exco InTouch CEO Tim Davis named an influential pharma individual

Exco InTouch CEO Tim Davis named an influential pharma individual

August 1, 2016
CenterWatch Staff

Exco InTouch, a provider of patient engagement and data capture solutions for clinical research and healthcare providers, has announced that its CEO and founder, Tim Davis, has been named as one of the most influential individuals in the pharmaceutical industry, for 2016.

Tim Davis has over 20 years of experience in the clinical research technology industry. He has been named in the PharmaVOICE 100 list due to the leading contribution that he has made in leveraging the advances in everyday technology to engage patients in clinical trials and healthcare programs.

Tim founded Exco InTouch in 2004 with the initial aim of utilizing mobile text messages to improve the patient’s journey through clinical trials—communicating with patients and reminding them of medication regimens, treatment instructions and site visits. The ultimate goal was to improve the healthcare experience for patients by providing support through everyday technology.

Under Tim’s leadership, Exco InTouch has leveraged advances in technology to continually improve its services, making effective use of smartphones, tablets, internet TVs and games consoles—continually breaking boundaries to bring new concepts to clinical trial participation. Innovations include the use of Xbox Kinect to create movement-based diaries for patients with osteoarthritis, activity trackers to augment primary data with information on patients’ general wellbeing, and capturing of physiological data directly from patients in their own homes through Bluetooth enabled medical devices such as blood glucose meters, spirometers and blood pressure monitors.

As part of his commitment to industry innovation, Tim pioneered the use of BYOD (bring your own device) data capture during clinical trials—for the first time enabling electronic capture of data from large, disperse patient populations in post-approval studies using their own mobile phones, tablets or computers.

Most recently the company has introduced the market to a revolutionary new product suite, Gather, which makes taking part in clinical trials much simpler and more engaging for everyone involved.

Beyond clinical trials, Tim Davis led the organization to develop a world leading digital health platform, which uses a combination of mobile apps, web portals and connected medical and lifestyle devices to help patients better understand and manage their conditions, whilst providing tools to enable healthcare professionals (HCPs) to remotely monitor each patient. This has already been implemented in a number of therapeutic areas including respiratory diseases, diabetes, hemophilia and dermatology.

Tim and Exco InTouch’s achievements have been widely recognized, winning many industry awards. For example, in 2015 Exco InTouch was named in both the Digital Health 100 and PharmaVoice’s Innovation companies, whilst also being included in the Sunday Times Hiscox TechTrack100—the annual list of the fastest growing privately-owned technology companies in the U.K.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing